O S Weislow
Overview
Explore the profile of O S Weislow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
763
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Riley J, Carroll R, Levine B, BERNSTEIN W, St Louis D, Weislow O, et al.
J Immunol
. 1997 Jun;
158(11):5545-53.
PMID: 9164979
When HIV-infected leukocytes are activated by the CD28 costimulatory receptor, HIV-1 is rapidly cleared from cultures, suggesting that costimulation can render T cells resistant to HIV-1 infection. In this study...
2.
Carroll R, Riley J, Levine B, Feng Y, Kaushal S, Ritchey D, et al.
Science
. 1997 Apr;
276(5310):273-6.
PMID: 9092480
Activation of CD4(+) T lymphocytes from human immunodeficiency virus-type 1 (HIV-1)-infected donors with immobilized antibodies to CD3 and CD28 induces a virus-resistant state. This effect is specific for macrophage-tropic HIV-1....
3.
Jones S, Cai D, Weislow O
Biotechniques
. 1997 Mar;
22(3):536-40, 542-3.
PMID: 9067034
Differential display is a method for the survey, analysis and comparison of gene expression in eukaryotic cells and tissues. Differential display involves isolation of high-quality nondegraded RNA, selective reverse transcription...
4.
Shafer R, Winters M, Mayers D, Japour A, Kuritzkes D, Weislow O, et al.
J Clin Microbiol
. 1996 Jul;
34(7):1849-53.
PMID: 8784610
Sequence-specific PCR was used in six laboratories and a ligase detection reaction was used in one laboratory to detect the zidovudine-resistance mutation at codon 215 of human immunodeficiency virus type...
5.
Levine B, Mosca J, Riley J, Carroll R, Vahey M, Jagodzinski L, et al.
Science
. 1996 Jun;
272(5270):1939-43.
PMID: 8658167
Because stimulation of CD4+ lymphocytes leads to activation of human immunodeficiency virus-type 1 (HIV-1) replication, viral spread, and cell death, adoptive CD4+ T cell therapy has not been possible. When...
6.
Mascola J, Snyder S, Weislow O, Belay S, Belshe R, Schwartz D, et al.
J Infect Dis
. 1996 Feb;
173(2):340-8.
PMID: 8568294
Phase I studies of volunteers not infected with human immunodeficiency virus type 1 (HIV-1) have shown that immunization with envelope subunit vaccine products elicits antibodies that neutralize laboratory-adapted (prototype) HIV-1...
7.
McMahon J, Gulakowski R, Weislow O, Schultz R, Narayanan V, Clanton D, et al.
Antimicrob Agents Chemother
. 1993 Apr;
37(4):754-60.
PMID: 7684215
A series of variously substituted diarylsulfones and related derivatives were found to prevent human immunodeficiency virus type 1 (HIV-1) replication and HIV-1-induced cell killing in vitro. One of the more...
8.
HOFFMAN P, Dhib-Jalbut S, Mikovits J, Robbins D, Wolf A, Bergey G, et al.
Proc Natl Acad Sci U S A
. 1992 Dec;
89(24):11784-8.
PMID: 1465399
The pathogenesis of progressive spastic paraparesis [HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)], a serious consequence of human T-cell leukemia virus type I (HTLV-I) infection, is unclear. T and B lymphocytes can...
9.
Gustafson K, Cardellina 2nd J, McMahon J, Gulakowski R, Ishitoya J, Szallasi Z, et al.
J Med Chem
. 1992 May;
35(11):1978-86.
PMID: 1597853
Extracts of Homalanthus nutans, a plant used in Samoan herbal medicine, exhibited potent activity in an in vitro, tetrazolium-based assay which detects the inhibition of the cytopathic effects of human...
10.
Clanton D, Moran R, McMahon J, Weislow O, Buckheit Jr R, Hollingshead M, et al.
J Acquir Immune Defic Syndr (1988)
. 1992 Jan;
5(8):771-81.
PMID: 1517963
Over 50 different commercially available sulfonic acid-containing dyes were analyzed for their ability to prevent HIV-1-induced cell killing and in inhibiting HIV-1 replication. Compounds of remarkably similar structure, but with...